US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial
20/08/2025 12:06
Aug 20 (Reuters) - Rocket Pharmaceuticals RCKT.O said on Wednesday that the U.S. Food and Drug Administration has lifted the clinical hold on its gene therapy mid-stage trial. (Reporting by Kamal Choudhury in Bengaluru; Editing by Sahal Muhammed) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Rocket Pharmaceuticals
See all newsRocket Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Rocket Pharmaceuticals, Inc. expected to post a loss of 42 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Rocket Pharmaceuticals posts Q2 profit helped by PRV sale
Brief: Rocket Pharmaceuticals Q2 EPS USD 1.08